Prevention, diagnosis, and treatment of venous thromboembolic complications of gynecologic surgery

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 4, 2001, Pages 759-775

  Davis, John D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Gynecologic surgery; Low molecular weight heparin; Methods of prevention; Venous thromboembolism

Indexed keywords

ARDEPARIN; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CLINICAL TRIAL; DEEP VEIN THROMBOSIS; GYNECOLOGIC SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THROMBOEMBOLISM;

EID: 0035085702     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.110957     Document Type: Article

References (81)

1. Prevention of venous thromboembolism in gynecologic surgery patients
2. Postanesthesia and postoperative care
3. Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery
4. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning
5. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin prophylaxis of deep vein thrombosis
6. Variables associated with postoperative deep venous thrombosis: A prospective study of 411 gynecology patients and creation of a prognostic model
7. Incidence of postoperative deep vein thrombosis in gynaecological oncology
8. 125I-labelled fibrinogen
9. Incidence of deep vein thrombosis
10. Venous thrombosis and pulmonary embolism
11. Low molecular weight heparin: Laboratory properties and clinical evaluation: A review
12. Prevention of fatal postoperative pulmonary embolism by low doses of heparin: An international multicentre trial
13. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin
14. Venous thromboembolism prophylaxis in gynecologic oncology: A prospective, controlled trial of low-dose heparin
15. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis
16. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery
17. Prevention of venous thromboembolism in general surgical patients: Results of meta-analysis
18. Low-molecular-weight heparins in clinical practice
19. Low molecular weight heparins and their use in obstetrics and gynecology
20. Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis
21. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
22. Comparison of low molecular weight heparin vs unfractionated heparin in gynecological surgery
23. Comparison of low molecular weight heparin vs unfractionated heparin in gynecologic surgery. II. Reduced dose of low molecular weight heparin
24. Efficacy safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
25. Enoxaparin: A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease
26. Type of compression for reducing venous stasis
27. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis
28. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery
29. Pneumatic compression stockings and prostaglandin synthesis: A pathway of fibrinolysis?
30. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy
31. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery
32. Fallibility of the clinical diagnosis of venous thrombosis
33. Roentgen diagnosis of venous thrombosis in the leg
34. Comparison of the accuracy of impedance plethysmography and compression ultrasonography in outpatients with clinically suspected deep vein thrombosis: A two centre paired-design prospective trial
35. Real-time ultrasound for the detection of deep vein thrombosis
36. Colour Doppler ultrasound in deep venous thrombosis: A comparison with venography
37. Comparison of duplex ultrasonography and venography in the diagnosis of deep venous thrombosis
38. Symptomatic lower extremity deep venous thrombosis: Accuracy, limitations, and role of color duplex flow imaging in diagnosis
39. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
40. Accuracy of clinical assessment of deep-vein thrombosis
41. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis
42. D-dimer testing in suspected venous thromboembolism: An update
43. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis
44. Management of venous thromboembolism
45. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis: A meta-analysis
46. Hemorrhagic complications of anticoagulant treatment
47. A standard heparin nomogram for the managment of heparin therapy
48. The weight-based heparin dosing nomogram compared with a "standard care" nomogram
49. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis
50. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
51. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis
52. Treatment of deep venous thrombosis with low-molecular-weight heparins
53. Low-molecular-weight heparins and unfractionated heparin in treatment of patients with acute venous thromboembolism: Results of a meta-analysis
54. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
55. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
56. A randomized trial comparing 5-mg and 10mg warfarin loading doses
57. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism
58. Optimal duration of oral anticoagulant therapy: A randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis
59. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
60. Interactions of warfarin with drugs and food
61. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis
62. Streptokinase
63. Inferior vena cava filters: Indications, safety, effectiveness
64. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac of pulmonary disease
65. The ECG in pulmonary embolism: Predictive value of negative T waves in precordial leads - 80 case reports
66. Enlargement of the right descending pulmonary artery in pulmonary embolism
67. Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism
68. Pulmonary embolism
69. Value of the ventilation/perfusion scan in acute pulmonary embolism Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) The PIOPED Investigators
70. Pulmonary embolism: Prospective comparison of spiral CT with ventilation-perfusion scintigraphy
71. Pulmonary embolism: Diagnosis with spiral CT and ventilation-perfusion scanning - Correlation with pulmonary angiographic results or clinical outcome
72. Acute pulmonary embolism: Assessment of helical CT for diagnosis
73. Clinically suspected pulmonary embolism: Utility of spiral CT
74. Opinions regarding the diagnosis and management of venous thromboembolic disease
75. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: A management study
76. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
77. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
78. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial